HYPERION DEFI, INC. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- HYPERION DEFI, INC. stock issued during period, value, stock options exercised for the quarter ending 2023-06-30 was $27.20K.
- HYPERION DEFI, INC. stock issued during period, value, stock options exercised for the quarter ending 2021-09-30 was $46.71K, a 10.41% decline year-over-year.
- HYPERION DEFI, INC. stock issued during period, value, stock options exercised for the quarter ending 2021-06-30 was $130.09K.
- HYPERION DEFI, INC. stock issued during period, value, stock options exercised for the quarter ending 2020-09-30 was $52.14K.
- HYPERION DEFI, INC. stock issued during period, value, stock options exercised for fiscal 2023 was $27.20K.
- HYPERION DEFI, INC. stock issued during period, value, stock options exercised for fiscal 2021 was $203.13K, a 147.23% increase from fiscal 2020.
- HYPERION DEFI, INC. stock issued during period, value, stock options exercised for fiscal 2020 was $82.16K, a 85.11% decline from fiscal 2019.
- HYPERION DEFI, INC. stock issued during period, value, stock options exercised for fiscal 2019 was $551.78K, a 876.91% increase from fiscal 2018.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2023-12-31 | $27.20K 10-K · filed 2025-04-15 | |
| 2023-06-30 | $27.20K 10-Q · filed 2024-11-12 | |
| 2021-12-31 | $203.13K 10-K · filed 2023-03-31 | |
| 2021-09-30 | $46.71K 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $130.09K 10-Q · filed 2022-11-14 | |
| 2020-12-31 | $82.16K 10-K · filed 2022-03-30 | |
| 2020-09-30 | $52.14K 10-Q · filed 2021-11-12 | |
| 2019-12-31 | $551.78K 10-K · filed 2021-03-30 | |
| 2019-06-30 | $67.89K 10-Q · filed 2020-11-12 | |
| 2019-03-31 | $483.89K 10-Q · filed 2020-11-12 | |
| 2018-12-31 | $56.48K 10-K · filed 2020-03-30 | |
| 2018-09-30 | $56.48K 10-Q · filed 2019-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |